![Page 1: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/1.jpg)
Chapter 4
Cellular Oncogenes
- 4.2 ~ 4.6 -
Mar 22, 2007
![Page 2: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/2.jpg)
Many retroviruses carrying oncogenes have been found in chickens and mice
![Page 3: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/3.jpg)
However, attempts undertaken during the 1970s to isolate viruses from most types of human tumors were unsuccessful.
Even reverse transcriptase-containing virus particles are difficult to find in human tumor samples.
![Page 4: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/4.jpg)
![Page 5: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/5.jpg)
Figure 4.2 (part 1 of 2) The Biology of Cancer (© Garland Science 2007)
Sidebar 4.2
(NIH3T3 cells)
4.2 Transfection of DNA provides a strategy for detecting nonviral oncogenes
transformed by 3-methycholanthrene
![Page 6: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/6.jpg)
Figure 4.2 (part 2 of 2) The Biology of Cancer (© Garland Science 2007)
(NIH3T3 cells)
DNA from tumor cells
The DNA from chemical-transformed tumor cells was able to convert non-tumorigenic NIH3T3 fibroblasts into tumorigenic cells.
![Page 7: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/7.jpg)
Figure 4.3 The Biology of Cancer (© Garland Science 2007)
Transfection of DNA from T24 human bladder carcinoma cell line into NIH3T3 cells
DNA from human cancers also cause focus formation
cells in the focus surrounding untransformed monolayer cells
focus formation
![Page 8: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/8.jpg)
4.3 Oncogenes discovered in human tumor cell lines are related to those carried by transforming retroviruses
Southern blotting (DNA) Northern blotting (RNA)
![Page 9: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/9.jpg)
Figure 4.4 (part 2) The Biology of Cancer (© Garland Science 2007)
nitrocellulose paper
( 32P-DNA)
![Page 10: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/10.jpg)
Figure 4.4 (part 3) The Biology of Cancer (© Garland Science 2007)
![Page 11: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/11.jpg)
Figure 4.5 The Biology of Cancer (© Garland Science 2007)
______________________________
11 (a ~ k) NIH3T3 cell lines transfected with DNA extracted from
a human bladder carcinoma cell line
untransfected NIH3T3
Homology between transfected oncogenesand retroviral oncogenes
probe used: H-ras oncogene present in Harvey rat sarcoma virus
![Page 12: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/12.jpg)
Table 4.1 The Biology of Cancer (© Garland Science 2007)
TK : tyrosine kinase
![Page 13: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/13.jpg)
Figure 4.6a The Biology of Cancer (© Garland Science 2007)
Amplification of the erbB2/HER2/neu oncogene in breast cancers
Kaplan-Meier plot
![Page 14: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/14.jpg)
Figure 4.6c The Biology of Cancer (© Garland Science 2007)
erbB2/neu oncogene is amplified
erbB2/neu mRNA is overexpressed
increased level of erbB2/neu-encoded protein
erbB2/HER2/neu oncogene can be amplified or overexpressed in human breast carcinoma cells
![Page 15: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/15.jpg)
Figure 4.8 The Biology of Cancer (© Garland Science 2007)
Cloning of transfected human oncogenes
Alu sequence - present in about 106
copies scattered throughout human genome
![Page 16: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/16.jpg)
Figure 4.9 The Biology of Cancer (© Garland Science 2007)
Localization of the mutation responsible for oncogene activity
cloned DNA of a human
bladder carcinoma oncogene
![Page 17: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/17.jpg)
Figure 4.10 The Biology of Cancer (© Garland Science 2007)
A point mutation is responsible for H-ras oncogene activation
![Page 18: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/18.jpg)
4.4 Proto-oncogenes can be activated by genetic changes affecting either protein expression or structure
![Page 19: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/19.jpg)
Figure 4.11a The Biology of Cancer (© Garland Science 2007)
homogeneous staining regions (HSR)
4.5 The myc oncogene can arise via at least three distinct mechanisms
The N-myc gene amplification is found in 30% of human childhood neuroblastoma.
Astrocytoma, retinoblastoma and small-cell lung carcinomas (neuroendocrinal traits) also often exhibit amplified N-myc genes.
* N-myc is a close relative of c-myc.
![Page 20: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/20.jpg)
Kaplan-Meier plot of childhood neuroblastomae
ven
t -
fre
e s
urv
iva
l
![Page 21: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/21.jpg)
Table 4.3 The Biology of Cancer (© Garland Science 2007)
![Page 22: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/22.jpg)
Activation of the myc protooncogenes 1. Gene amplification
10 ~ 30 copies or 100 ~ 150 copies
shown as homogeneously staining regions (HSR) or double minutes (DM)
2. Provirus integration - insertional mutagenesis
constitutive expression by insertion of retroviruses
3. Chromosomal translocation
![Page 23: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/23.jpg)
Figure 3.23b The Biology of Cancer (© Garland Science 2007)
transcription of myc gene is controlled by viral promoters
excessive myc protein
Insertional mutagenesis
![Page 24: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/24.jpg)
Figure 4.12 The Biology of Cancer (© Garland Science 2007)
Burkitt’s lymphoma in Africa
(Aedes simpsoni)
Malarial infection Epstein-Barr virus (EBV) genome in Burkitt’s lymphoma cells
![Page 25: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/25.jpg)
Figure 4.13a The Biology of Cancer (© Garland Science 2007)
Chromosome translocations in Burkitt’s lymphoma
The expression of c-myc gene is placed under control of the trancription-controlling enhancer sequences of an immunoglobulin heavy chain (IgH) gene.
![Page 26: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/26.jpg)
Figure 4.13b The Biology of Cancer (© Garland Science 2007)
Genetic map of the translocation event of c-myc gene
The c-myc gene is translocated into chromosome 8, under the control of the immunoglobulin heavy-chain (IgH) sequences present on human chromosome 14
![Page 27: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/27.jpg)
Table 4.4 The Biology of Cancer (© Garland Science 2007)
![Page 28: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/28.jpg)
Figure 4.14 The Biology of Cancer (© Garland Science 2007)
4.6 A diverse array of structural changes in proteins can also lead to oncogene activation
(GF)
![Page 29: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/29.jpg)
Figure 2.23a The Biology of Cancer (© Garland Science 2007)
Philadelphia chromosome (Ph1)
The great majority (> 95 %) of chronic myelogenous leukemia (CML) has t(9; 22) (q34; q11) translocation
![Page 30: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/30.jpg)
Figure 4.15a The Biology of Cancer (© Garland Science 2007)
Formation of the bcr-abl oncogene after t(9; 22) (q34; q11) translocation
(Abelson murine leukemia virus)
(breakpoint cluster region)
![Page 31: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/31.jpg)
Figure 4.15b The Biology of Cancer (© Garland Science 2007)
Different breakpoints in bcr results in different types of human leukemia
acute lymphocytic leukemia
chronic myelogenousleukemia
chronic neutrophilic leukemia
↓ a ↓b ↓c
↓
↓
Abl↑
a.
b.
c.
Bcr
Bcr-Abl fusion protein
![Page 32: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/32.jpg)
Table 4.5 The Biology of Cancer (© Garland Science 2007)
![Page 33: Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Mar 22, 2007](https://reader035.vdocuments.us/reader035/viewer/2022062408/56649e995503460f94b9c3ff/html5/thumbnails/33.jpg)
Notations used for proto-oncogenes and oncogenes
gene protein
Non-human src, myc Src, Myc(chicken, mouse, etc.)
Human SRC, MYC SRC, MYC